187 related articles for article (PubMed ID: 8701560)
21. [Bladder and sphincter disorders in multiple sclerosis. Clinical, urodynamic and neurophysiological study of 225 cases].
Amarenco G; Kerdraon J; Denys P
Rev Neurol (Paris); 1995 Dec; 151(12):722-30. PubMed ID: 8787103
[TBL] [Abstract][Full Text] [Related]
22. [Urination disorders in multiple sclerosis: value of urodynamic assessment].
Gallien P; Le Bot-Le Borgne MP; Nicolas B; Robineau S; Toulouse P; Brissot R; Edan G
J Urol (Paris); 1994; 100(6):294-8. PubMed ID: 7745258
[TBL] [Abstract][Full Text] [Related]
23. Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system.
Ukkonen M; Elovaara I; Dastidar P; Tammela TL
Acta Neurol Scand; 2004 Feb; 109(2):100-5. PubMed ID: 14705971
[TBL] [Abstract][Full Text] [Related]
24. Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis).
Fowler CJ; van Kerrebroeck PE; Nordenbo A; Van Poppel H
J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):986-9. PubMed ID: 1469417
[TBL] [Abstract][Full Text] [Related]
25. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis.
Betts CD; D'Mellow MT; Fowler CJ
J Neurol Neurosurg Psychiatry; 1993 Mar; 56(3):245-50. PubMed ID: 8459239
[TBL] [Abstract][Full Text] [Related]
26. Role of limited evaluation and aggressive medical management in multiple sclerosis: a review of 113 patients.
Sirls LT; Zimmern PE; Leach GE
J Urol; 1994 Apr; 151(4):946-50. PubMed ID: 8126834
[TBL] [Abstract][Full Text] [Related]
27. Urodynamic studies in female patients with multiple sclerosis.
Beck RP; Warren KG; Whitman P
Am J Obstet Gynecol; 1981 Feb; 139(3):273-6. PubMed ID: 7468694
[TBL] [Abstract][Full Text] [Related]
28. Voiding dysfunction in Shy-Drager syndrome.
Wheeler JS; Canning JR
J Urol; 1985 Aug; 134(2):362-3. PubMed ID: 4020994
[TBL] [Abstract][Full Text] [Related]
29. [A clinical study of voiding status in multiple sclerosis patients].
Komatsu K; Nagano K; Yokoyama O; Kawaguchi K; Hisazumi H; Hayashi S
Hinyokika Kiyo; 1991 Jan; 37(1):25-9. PubMed ID: 2011964
[TBL] [Abstract][Full Text] [Related]
30. Nonneurogenic voiding disorders in children and adolescents: clinical and videourodynamic findings in 4 specific conditions.
Glassberg KI; Combs AJ; Horowitz M
J Urol; 2010 Nov; 184(5):2123-7. PubMed ID: 20850821
[TBL] [Abstract][Full Text] [Related]
31. Acute urinary retention in herpes genitalis infection. Urodynamic evaluation.
Greenstein A; Matzkin H; Kaver I; Braf Z
Urology; 1988 May; 31(5):453-6. PubMed ID: 3363783
[TBL] [Abstract][Full Text] [Related]
32. Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction.
McGuire EJ; Savastano JA
J Urol; 1984 Oct; 132(4):713-5. PubMed ID: 6147423
[TBL] [Abstract][Full Text] [Related]
33. Evaluation and management of the urologic consequences of neurologic disease.
Kotkin L; Milam DF
Tech Urol; 1996; 2(4):210-9. PubMed ID: 9085542
[TBL] [Abstract][Full Text] [Related]
34. Clinical Characteristics and Urodynamic Analysis of Urinary Dysfunction in Multiple Sclerosis.
Wang T; Huang W; Zhang Y
Chin Med J (Engl); 2016 Mar; 129(6):645-50. PubMed ID: 26960366
[TBL] [Abstract][Full Text] [Related]
35. Urodynamic effects of alpha1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder.
Kakizaki H; Ameda K; Kobayashi S; Tanaka H; Shibata T; Koyanagi T
Int J Urol; 2003 Nov; 10(11):576-81. PubMed ID: 14633081
[TBL] [Abstract][Full Text] [Related]
36. Neurogenic bladder in the woman with multiple sclerosis.
Summers JL
J Urol; 1978 Nov; 120(5):555-6. PubMed ID: 712896
[TBL] [Abstract][Full Text] [Related]
37. Neurophysiology of the striated urethral sphincter in multiple sclerosis.
Eardley I; Nagendran K; Lecky B; Chapple CR; Kirby RS; Fowler CJ
Br J Urol; 1991 Jul; 68(1):81-8. PubMed ID: 1873695
[TBL] [Abstract][Full Text] [Related]
38. Schistosomal myelopathy: urologic manifestations and urodynamic findings.
Gomes CM; Trigo-Rocha F; Arap MA; Gabriel AJ; Alaor de Figueiredo J; Arap S
Urology; 2002 Feb; 59(2):195-200. PubMed ID: 11834384
[TBL] [Abstract][Full Text] [Related]
39. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction.
Welk B; Hickling D; McKibbon M; Radomski S; Ethans K
Neurourol Urodyn; 2018 Nov; 37(8):2810-2817. PubMed ID: 30168626
[TBL] [Abstract][Full Text] [Related]
40. [Help for patients with multiple sclerosis: current diagnostic and treatment possibilities in neurogenic disorders of bladder emptying].
Zwergel U; Wullich B; Jost WH; Zwergel T
Dtsch Med Wochenschr; 1998 May; 123(22):707-12. PubMed ID: 9645188
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
